Healthier Capital

Healthier Capital is a venture capital investment firm established in 2023 and located in Palo Alto, United States. The firm is dedicated to enhancing healthcare impact and value development by collaborating with innovative technology-driven healthcare companies. Healthier Capital aims to promote healthier outcomes for all by partnering with exceptional innovators in the industry, focusing on combining impactful advancements with meaningful value creation in the healthcare sector.

Amir Dan Rubin

CEO and Founding Managing Partner

5 past transactions

Qualified Health

Seed Round in 2025
Qualified Health is a technology company specializing in generative artificial intelligence (AI) for healthcare. It provides an infrastructure solution that ensures safe and effective use of AI in medicine, offering features such as continuous algorithm performance monitoring, active AI governance, and customizable AI agents tailored to healthcare needs. The company partners with leading health systems in the U.S. to revolutionize healthcare through AI.

Hyro

Series B in 2024
Hyro is a developer of a conversational artificial intelligence platform that simplifies user interactions across various digital channels. The platform leverages natural language understanding to create plug-and-play AI assistants that enable users to engage with information through voice or chat. By automatically building a knowledge graph from existing content, Hyro allows organizations to deploy and maintain their solutions with minimal friction, eliminating the need for extensive integration, playbooks, or training data. Additionally, the platform includes advanced analytics and conversation editing capabilities, enabling businesses to customize navigation and enhance customer engagement effectively.

Medeloop

Series A in 2024
Medeloop is a pioneering platform that enhances medical research through advanced artificial intelligence and a robust data linkage infrastructure. It integrates and analyzes vast amounts of health data, transforming it into a graph database that provides deeper insights and connectivity. This technology streamlines the clinical research process by offering research hypotheses for underexplored diseases, thereby enabling researchers to publish findings more efficiently. Additionally, Medeloop features a patient-facing application that empowers individuals to monitor their health information and actively contribute to significant medical research. By facilitating collaboration among patients, providers, and researchers, Medeloop aims to accelerate the discovery of biomarkers and potential drug targets, ultimately improving treatment development and saving lives.

Amae Health

Series A in 2024
Amae Health is a mental wellness clinic that offers specialized care for individuals with severe mental illness. The clinic focuses on understanding the unique needs of its patients and provides tailored treatment solutions that integrate behavioral medicine, primary care, and social health. By addressing these diverse aspects of care, Amae Health aims to help patients and their families stabilize and thrive, while also working to prevent future adverse health events. Through its comprehensive approach, the clinic seeks to enhance health outcomes for those it serves.

Ezra AI

Series B in 2024
Ezra AI, Inc. specializes in developing artificial intelligence technology-based investigational devices aimed at early cancer detection. The company utilizes full-body MRI scans enhanced by AI to innovate cancer screening methods. Its initial product, an AI software designed to assist radiologists in interpreting prostate MRI images, has received FDA clearance as a medical device. Founded in 2017, Ezra AI is headquartered in New York, New York, and primarily serves customers in New York and California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.